8 withdrawn. 8 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Withdrawn 8 |
| Phase 2 | 3 | Withdrawn 3 |
Follow Ischemic Stroke: new trials by email Literature Review of Ischemic Stroke trials Research Report on Ischemic Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glenzocimab in Anterior Stroke With Large Ischemic Core Eligible for Endovascular Therapy glenzocimab, placebo - Acute Ischemic Stroke | Phase 2 / Phase 3 | Withdrawn | Fondation Ophtalmologique Adolphe de Rothschild | 2026-09-01 | 2026-09-09 | |
| Efficacy and Safety Evaluation of 3K3A-APC in Ischemic Stroke 3K3A-APC, Placebo - Ischemic Stroke | Phase 3 | Withdrawn | ZZ Biotech, LLC | 2024-10-01 | 2024-10-01 | |
| Earlier Mobilization Post Acute Thrombolysis Mobilization - Stroke, Stroke, Acute | Phase 3 | Withdrawn | Brian Silver | 2023-08-01 | 2023-10-30 | |
| Earlier Mobilization Post Acute Thrombectomy Mobilization - Stroke, Stroke, Acute | Phase 3 | Withdrawn | Brian Silver | 2023-08-01 | 2023-10-30 | |
| Pilot Study of Ketamine Sedation for Aneurysmal Subarachnoid Hemorrhage Ketamine Hydrochloride, Propofol - Subarachnoid Hemorrhage, Aneurysmal | Phase 2 / Phase 3 | Withdrawn | Jenna L Leclerc MD, PhD | 2023-04-27 | 2023-05-01 | |
| Paediatric Arteriopathy Steroid Aspirin Project Methylprednisolone + prednisolone - Arterial Ischemic Stroke | Phase 3 | Withdrawn | Centre Hospitalier Universitaire de Saint Etienne | 2022-09-01 | 2022-10-19 | |
| Intensive Blood Pressure Intervention in Stroke (IBIS) Trial Blood pressure lowering strategy - Ischemic Stroke | Phase 3 | Withdrawn | Tulane University | 2018-01-01 | 2023-02-16 | |
| Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN) Tenecteplase, Alteplase - Ischemic Stroke | Phase 2 / Phase 3 | Withdrawn | Reza Behrouz, DO | 2015-01-01 | 2015-09-23 |
Stroke (3) · Brain Diseases (2) · Cerebrovascular Disorders (2) · Ischemia (2) · Cerebral Infarction (1) · Subarachnoid Hemorrhage (1)
Cardiovascular Diseases (8) · Central Nervous System Diseases (8) · Nervous System Diseases (8) · Vascular Diseases (8) · Brain Diseases (6) · Cerebrovascular Disorders (6) · Stroke (5) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Brain Infarction (1) · Brain Ischemia (1) · Hemorrhage (1) · Infarction (1) · Intracranial Hemorrhages (1) · Ischemia (1)
3K3A-APC protein (1) · Ketamine (1) · Methylprednisolone (1) · Prednisolone (1) · Propofol (1) · Tenecteplase (1) · Tissue Plasminogen Activator (1) · glenzocimab (1)
Brian Silver (2) · Centre Hospitalier Universitaire de Saint Etienne (1) · Fondation Ophtalmologique Adolphe de Rothschild (1) · Jenna L Leclerc MD, PhD (1) · Reza Behrouz, DO (1) · Tulane University (1) · ZZ Biotech, LLC (1)
United States (1)
Brian Silver, MD (2) · Jenna L Leclerc, MD, PhD (1) · Jiang He, MD, PhD (1) · Patrick D Lyden, MD (1) · Reza Behrouz, DO (1) · Yilong Wang (1)
PMID 26387127, PMID 32905623, PMID 36398903
2017 (1), UG3NS119199 (1)